| Estimated beta | Likelihood ratio test | Adjusted ROR (95 % CI) | |
---|---|---|---|---|
Total | Â | Â | Â | Â |
 Reporting Year | −0.025 | <0.0001b | 0.98 | (0.97-0.98) |
 Gender female | 0.104 | <0.0001b | 1.11 | (1.06-1.17) |
 Age |  |  |  |  |
   ≤ 19 years | 0.284 | <0.0001b | 1.33 | (1.21-1.45) |
  20-39 years | 0.579 | <0.0001b | 1.78 | (1.65-1.93) |
  40–59 yearsa |  |  |  |  |
  60–79 years | −0.349 | <0.0001b | 0.71 | (0.66-0.75) |
   ≥ 80 years | −0.327 | <0.0001b | 0.72 | (0.66-0.79) |
Allopurinol | Â | Â | Â | Â |
 Reporting Year | 0.005 | 0.7756 | 1.00 | (0.97-1.04) |
 Gender female | 0.630 | <0.0001b | 1.88 | (1.54-2.29) |
 Age |  |  |  |  |
   ≤ 19 years | −1.515 | 0.0713 | 0.22 | (0.01-1.11) |
  20-39 years | 0.165 | 0.4712 | 1.18 | (0.75-1.82) |
  40–59 yearsa |  |  |  |  |
  60–79 years | −0.123 | 0.3285 | 0.88 | (0.69-1.13) |
   ≥ 80 years | 0.073 | 0.6324 | 1.08 | (0.80-1.45) |
Loxoprofen | Â | Â | Â | Â |
 Reporting Year | −0.027 | 0.0706 | 0.97 | (0.95-1.00) |
 Gender female | −0.150 | 0.1154 | 0.86 | (0.71-1.04) |
 Age |  |  |  |  |
   ≤ 19 years | 0.429 | 0.0751 | 1.54 | (0.96-2.39) |
  20-39 years | 0.635 | <0.0001b | 1.89 | (1.49-2.39) |
  40–59 yearsa |  |  |  |  |
  60–79 years | −0.535 | <0.0001b | 0.59 | (0.46-0.75) |
   ≥ 80 years | −1.399 | <0.0001b | 0.25 | (0.14-0.41) |
Acetaminophen | Â | Â | Â | Â |
 Reporting Year | 0.023 | 0.1744 | 1.24 | (0.89-1.73) |
 Gender female | 0.287 | 0.0082b | 1.33 | (1.08-1.65) |
 Age |  |  |  |  |
   ≤ 19 years | 0.230 | 0.1292 | 1.26 | (0.94-1.70) |
  20-39 years | 0.266 | 0.0972 | 1.31 | (0.95-1.79) |
  40–59 yearsa |  |  |  |  |
  60–79 years | −0.184 | 0.2818 | 0.83 | (0.60-1.16) |
   ≥ 80 years | −1.103 | 0.0004b | 0.33 | (0.16-0.62) |
Carbamazepine | Â | Â | Â | Â |
 Reporting Year | 0.005 | 0.7666 | 1.00 | (0.97-1.04) |
 Gender female | 0.187 | 0.0765 | 1.21 | (0.98-1.48) |
 Age |  |  |  |  |
   ≤ 19 years | 0.083 | 0.6486 | 1.09 | (0.76-1.55) |
  20-39 years | 0.360 | 0.0209b | 1.43 | (1.06-1.95) |
  40–59 yearsa |  |  |  |  |
  60–79 years | 0.416 | 0.0027b | 1.52 | (1.15-2.00) |
  ≥80 years | −0.419 | 0.1293 | 0.66 | (0.36-1.12) |
Lamotrigine | Â | Â | Â | Â |
 Reporting Year | 0.036 | 0.3618 | 1.04 | (0.96-1.12) |
 Gender female | 0.158 | 0.1978 | 1.17 | (0.92-1.49) |
 Age |  |  |  |  |
   ≤ 19 years | −0.992 | <0.0001b | 0.37 | (0.22-0.60) |
  20-39 years | −0.418 | 0.0034b | 0.66 | (0.50-0.87) |
  40–59 yearsa |  |  |  |  |
  60–79 years | −0.176 | 0.2672 | 0.84 | (0.61-1.14) |
   ≥ 80 years | 0.162 | 0.5984 | 1.18 | (0.63-2.09) |